GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Columbia Care Inc (XCNQ:CCHW) » Definitions » EV-to-EBITDA

Columbia Care (XCNQ:CCHW) EV-to-EBITDA : 42.69 (As of Jul. 19, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Columbia Care EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Columbia Care's enterprise value is C$915.8 Mil. Columbia Care's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was C$21.5 Mil. Therefore, Columbia Care's EV-to-EBITDA for today is 42.69.

The historical rank and industry rank for Columbia Care's EV-to-EBITDA or its related term are showing as below:

XCNQ:CCHW' s EV-to-EBITDA Range Over the Past 10 Years
Min: -81.34   Med: -9.37   Max: 153.52
Current: 30.76

During the past 7 years, the highest EV-to-EBITDA of Columbia Care was 153.52. The lowest was -81.34. And the median was -9.37.

XCNQ:CCHW's EV-to-EBITDA is ranked worse than
76.51% of 728 companies
in the Drug Manufacturers industry
Industry Median: 14.565 vs XCNQ:CCHW: 30.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-07-19), Columbia Care's stock price is C$0.56. Columbia Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was C$0.000. Therefore, Columbia Care's PE Ratio (TTM) for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Columbia Care EV-to-EBITDA Historical Data

The historical data trend for Columbia Care's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Columbia Care EV-to-EBITDA Chart

Columbia Care Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial -17.16 -21.61 93.55 16.12 16.42

Columbia Care Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.28 11.46 5.72 16.42 31.29

Competitive Comparison of Columbia Care's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Columbia Care's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Columbia Care's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Columbia Care's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Columbia Care's EV-to-EBITDA falls into.


;
;

Columbia Care EV-to-EBITDA Calculation

Columbia Care's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=915.798/21.453
=42.69

Columbia Care's current Enterprise Value is C$915.8 Mil.
Columbia Care's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$21.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Columbia Care  (XCNQ:CCHW) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Columbia Care's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.56/0.000
=N/A

Columbia Care's share price for today is C$0.56.
Columbia Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Columbia Care EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Columbia Care's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Columbia Care Business Description

Traded in Other Exchanges
Address
321 Billerica Road, Suite 204, Chelmsford, MA, USA, 01824
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.

Columbia Care Headlines

No Headlines